References
- 1MillerLGJankovicJMetoclopramide-induced movement disorders. Clinical findings with a review of the literatureArch Intern Med198914924862492doi: 10.1001/archinte.1989.003901100700152684075
- 2PasrichaPJPehlivanovNSugumarAJankovicJDrug Insight: from disturbed motility to disordered movement--a review of the clinical benefits and medicolegal risks of metoclopramideNat Clin Pract Gastroenterol Hepatol20063138148doi: 10.1038/ncpgasthep044216511548
- 3BurkhardPRAcute and subacute drug-induced movement disordersParkinsonism Relat Disord201420Suppl 1S108S112doi: 10.1016/S1353-8020(13)70027-024262159
- 4van HartenPNHoekHWKahnRSAcute dystonia induced by drug treatmentBMJ1999319623626doi: 10.1136/bmj.319.7210.62310473482
